SCHEMBL15514489

SCHEMBL15514489

C=Cc1ccc(OCC2CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 4/20 0.50
PARP10 Q53GL7 4/20 0.50
PARP2 Q9UGN5 2/20 0.50
HPGD P15428 4/20 0.47
TDP1 Q9NUW8 1/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA7 P36544 1/20 0.45
CHRNA4 P43681 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9943601 0.84 PARP15 (0.55) PARP15PARP10PARP2HPGDCHRNB2
SCHEMBL29024848 0.83 PARP15 (0.64) PARP15PARP10PARP2TDP1SIGMAR1
SCHEMBL19834476 0.83 ACACA (0.52)
SCHEMBL572868 0.83 CHRNB2 (0.39) PARP15PARP10PARP2HPGDCHRNB2
SCHEMBL8314306 0.81 PARP15 (0.54) PARP15PARP10PARP2HPGDTDP1
SCHEMBL3718600 0.81 PARP15 (0.54) PARP15PARP10PARP2HPGDTDP1
SCHEMBL8312964 0.81 PARP15 (0.54) PARP15PARP10PARP2HPGDTDP1
SCHEMBL10010079 0.81 PARP10 (0.45) PARP15PARP10PARP2HPGD
SCHEMBL573151 0.78 TDP1 (0.59) HPGDTDP1CHRNB2CHRNB4CHRNA3
SCHEMBL3828236 0.78 TDP1 (0.59) HPGDTDP1CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220396583-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING NEUROPORE THERAPIES, INC. (US) 2022-12-15 US disclosed
US-11345713-B2 Compounds as modulators of TLR2 signaling NEUROPORE THERAPIES, INC. (US) 2022-05-31 US disclosed
EP-3774736-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING Neuropore Therapies, Inc. (US) 2021-02-17 EP disclosed
US-20210024539-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING NEUROPORE THERAPIES, INC. (US) 2021-01-28 US disclosed
WO-2019191189-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING NEUROPORE THERAPIES, INC. (US) 2019-10-03 WO disclosed
WO-2019191189-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING NEUROPORE THERAPIES, INC. (US) 2019-10-03 WO disclosed
EP-2797110-B1 INSULATION-LAYER MATERIAL FOR ELECTRONIC DEVICE, AND ELECTRONIC DEVICE SUMITOMO CHEMICAL CO (JP) 2018-02-28 EP disclosed
US-9461257-B2 Electronic device insulating layer, and method for producing electronic device insulating layer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-04 US disclosed
CN-104040700-B Insulating electronic device layer material and electronic device 住友化学株式会社 2016-09-07 CN disclosed
US-9362512-B2 Electronic device insulating layer material capable of forming an insulating layer at low temperature SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-07 US disclosed
US-20150236281-A1 INSULATION-LAYER MATERIAL FOR ELECTRONIC DEVICE, AND ELECTRONIC DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-08-20 US disclosed
US-9035292-B2 Organic thin-film transistor insulating layer material SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-05-19 US disclosed
US-20150008418-A1 ELECTRONIC DEVICE INSULATING LAYER, AND METHOD FOR PRODUCING ELECTRONIC DEVICE INSULATING LAYER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-01-08 US disclosed
CN-104137236-A Electronic device insulating layer and method for manufacturing electronic device insulating layer SUMITOMO CHEMICAL CO 2014-11-05 CN disclosed
EP-2797110-A1 INSULATION-LAYER MATERIAL FOR ELECTRONIC DEVICE, AND ELECTRONIC DEVICE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2014-10-29 EP disclosed
CN-104040700-A INSULATION-LAYER MATERIAL FOR ELECTRONIC DEVICE, AND ELECTRONIC DEVICE SUMITOMO CHEMICAL CO 2014-09-10 CN disclosed
US-20140070205-A1 ORGANIC THIN-FILM TRANSISTOR INSULATING LAYER MATERIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345713-B2 Compounds as modulators of TLR2 signaling TLR2, TLR4, TLR3 PARP15 1928/4885PARP10 1695/4885PARP2 1801/4885
US-20220396583-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING TLR2, TLR4, TLR3 PARP15 1928/4885PARP10 1695/4885PARP2 1801/4885
US-20210024539-A1 COMPOUNDS AS MODULATORS OF TLR2 SIGNALING TLR2, TLR4, TLR3 PARP15 1928/4885PARP10 1695/4885PARP2 1801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.